Discovery could revive failed treatments for solid tumours
New research from UVA Cancer Center, USA, could rescue once-promising immunotherapies for treating solid cancer…
Browsing: Immunotherapy
Novel cancer vaccine targets oncogenes known to evade immunity in melanoma and neuroblastoma models
A personalised tumour cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an…
High thrombotic risk in cancer patients receiving immunotherapy
Cancer patients generally have a higher thrombotic risk than the population at large. This risk…
Vaccination against mutated protein tested in brain tumor patients for the first time
Diffuse gliomas are usually incurable brain tumours that spread in the brain and are difficult…
Engineered immune cells deliver anticancer signal, prevent cancer from spreading
Scientists have genetically engineered immune cells, called myeloid cells, to precisely deliver an anticancer signal…
Immunotherapy appears to fuel tumour growth in liver cancer related to underlying liver condition NASH
Researchers found for the first time that immunotherapy is significantly less effective in liver cancer…
Deactivating cancer cell gene boosts immunotherapy for head and neck cancers
By targeting an enzyme that plays a key role in head and neck cancer cells,…
Researchers find cellular evidence behind lasting immune response in some cancer survivors
Some melanoma patients respond very well to immunotherapy, experiencing profound and durable tumour regression. A…
Exploiting cancer cells to aid in their own destruction
Immunotherapy, which recruits the body’s own immune system to attack cancer, has given many cancer…
Forty-three percent of melanoma patients have chronic complications from immunotherapies
Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than…